Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT02509351
Brief Summary:
* Misoprostol reduces the uterine bleeding after cesarean delivery without harmful effects on either mother or baby.
* The aim of the this study is to address if there is any benefits 'regarding the intra-operative blood loss' from preoperative rectal administration of 400 mic of Misoprostol in addition to the routinely administrated 10 units of oxytocin
Detailed Description:
Research question:
In women undergoing elective ceserean section, is preoperative 400 mic Misoprostol reduce intra-operative blood loss?
Research hypothesis:
pre-operative Misoprostol doesn't reduce intraoperative blood loss in women undergoing ceserean section
Study:
NCT02509351
Study Brief:
Protocol Section:
NCT02509351